Bylvay (odevixibat), an oral medication used to treat cholestatic pruritus — severe itching that results from a buildup of bile acids used in digestion — is now approved in Canada for people with Alagille syndrome. The decision by Health Canada will make the Ipsen medication available to adults and children, ages 1 and older, with […] The post Bylvay now approved in Canada to treat adults, children with Alagille appeared first on Liver Disease News.
